Stress-Driven Brain Remodeling in Opioid Use Disorder: Toward a Neuroprogressive Model

Background: Opioid use disorder (OUD) is classically understood through reward dysregulation, opponent processes, and allostatic adaptation, but these models only partly account for the persistent cognitive, affective, and stress-regulatory abnormalities observed in some individuals with long-standing OUD. Methods: This Perspective integrates human evidence from neuroendocrinology, neuroimaging, and neurocognitive research with mechanistic findings from preclinical opioid-exposure and withdrawal models. Throughout the revised framework, direct evidence in humans is distinguished from cross-species mechanistic inference. Results: Repeated opioid exposure induces neuroadaptations that initially compensate for persistent pharmacological perturbation. When exposure is prolonged and accompanied by recurrent intoxication-withdrawal cycling, these adaptations may become increasingly maladaptive and interact with repeated stress-system destabilization. Human studies document abnormalities in hypothalamic-pituitary-adrenal (HPA) axis regulation, brain structure and connectivity, and executive-cognitive functioning in OUD, whereas preclinical studies provide plausible mechanisms involving glucocorticoid and extrahypothalamic corticotropin-releasing factor (CRF) signaling, noradrenergic and dynorphin systems, synaptic plasticity, neuroimmune activation, and cellular stress. We propose a staged continuum from neuroadaptation to maladaptive brain remodeling and, potentially, neuroprogression. At the advanced end of this continuum, we describe a provisional neuroprogressive phenotype characterized by persistent multidomain dysfunction in stress regulation, cognitive-executive processing, affective regulation, and behavioral control beyond acute intoxication or withdrawal in a vulnerable subset of individuals with OUD. Conclusions: The proposed neuroprogressive model defines a testable hypothesis in which cumulative opioid exposure and recurrent withdrawal-related stress burden may contribute to persistent loss of adaptive capacity. Treatment-related stabilization and partial recovery are incorporated into the model, but disease-modifying effects of opioid agonist treatment remain to be demonstrated prospectively. Longitudinal multimodal studies are required to establish the existence, boundaries, prevalence, reversibility, and clinical utility of the proposed phenotype.